Schurer, A., Ilyas, H., Maron, M., Hegde, S., Leyden, M., Roy, I., Hyka, R., Dada, L., Shabanowitz, J., Hunt, D., Angeles, E., Morell, V., Lorton, B., Glushakow-Smith, S., Borger, D., Wang, Y., Miles, L., Belizaire, R., Kitamura, S., Gritsman, K., Shechter, D. (2025). TTLL4 glutamyltransferase is a therapeutic target for NPM1-mutated Acute Myeloid Leukemia. Blood. https://doi.org/10.1182/blood-2025-869